期刊文献+

2004至2013年全国中孕期母血清产前筛查室间质量评价 被引量:12

External quality assessment of maternal serum prenatal screening in second trimester during 2004-2013 in China
原文传递
导出
摘要 目的 总结分析2004至2013年全国中孕期母血清产前筛查室间质量评价的实验室结果,为提高产前筛查质量提供参考.方法 2004至2013年卫生部临检中心每次室间质量评价活动发放5个不同浓度的质控品,要求各产前筛查实验室检测并在规定的时间内回报结果,评价实验室检测甲胎蛋白(AFP)、人绒毛膜促性腺激素(HCG)、人绒毛膜促性腺激素β-亚基(β-HCG)、人绒毛膜促性腺激素游离β-亚基(freeβ-HCG)、未结合雌三醇(uE3)的能力.结果 2004至2013年参加实验室数量从57家增加到500家;AFP的稳健变异系数2.77% ~ 18.98%,HCG稳健变异系数5.6%~36.12%,β-HCG稳健变异系数4.69% ~ 24.38%,freeβ-HCG稳健变异系数2.66% ~ 81.54%,uE3稳健变异系数3.83% ~26.51%;AFP的合格率93% (463/496),HCG的合格率66%(35/53),β-HCG合格率85%(137/161),free β-HCG(μg/L)的合格率从52%(24/46)增加到94%(248/264),free β-HCG(mIU/ml)的合格率为47% (18/38),uE3的实验室合格率达84%(252/299).结论 中孕期产前筛查AFP项目检测水平较好,其次为β-HCG项目,其他项目仍存在一定问题,我国仍需重视室间质量评价、建立全面的质量控制体系提高中孕期母血清产前筛查的检测水平. Objective To summarize and analyze the results of national external quality assessment (EQA) of maternal serum prenatal screening in second trimester during 2004-2013,in order to provide a assistance for the quality improvement of the prenatal screening testing.Methods Five different concentration samples were distributed to each participated laboratories and were measured at each external quality assessment program during 2004 to 2013.The results reported in a specified time.The testing performance of alpha fetoprotein (AFP),total human chorionic gonadotropin (HCG),total β-human chorionic gonadotropin (β-HCG),free β-human chorionic gonadotropin (free β-HCG),unconjugated estriol (uE3) were evaluated.Results During 2004-2013,the number of laboratory participated increased from 57 to 500.The robust variation coefficient increased from 2.77% to 18.98% for AFP,5.6% to 36.12% for HCG,4.69% to 24.38% for β-HCG,2.66% to 81.54% for free β-HCG,and 3.83% to 26.51% for uE3.The percentage of passing rate reached 93% (463/496) for AFP,66% (35/53)for HCG,85% (137/ 161) for β-HCG.The percentage of passing of free β-HCG (μg/L) increased from 52 % (24/46) to 94% (248/264),but the passing percentage of free β-HCG (mIU/ml) were 47% (18/38).The percentage of passing of uE3 reached 84% (252/299).Conclusions The testing performance of AFP is best in prenatal screening,followed by β-HCG,other item testing have some problems.It is great important to improve the quality of maternal serum prenatal screening by strengthening external quality assessment and building comprehensive quality control system in China.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2014年第4期270-275,共6页 Chinese Journal of Laboratory Medicine
关键词 妊娠中期 产前诊断 甲胎蛋白类 Pregnancy trimester,second Prenatal diagnosis alpha-Fetoproteins
  • 相关文献

参考文献6

二级参考文献34

  • 1Xie ZW, Lu SM, Zhu YN, et al. Second-trimester maternal serum free-beta-human chorionic gonadotropin and alpha-fetoprotein levels in normal twin and singleton pregnancies: a report of local Chinese population. Prenat Diagn,2008, 28: 735-738.
  • 2Evans M, Cuckle H. The Global Library of Women's Medicine,ISSN:1756-2228. 2008. DOI 10. 3843/GLOWM. 10222.
  • 3Kooper AJ, Faas BH, Feuth T, et al. Detection of chromosome aneuploidies in chorionic villus samples by multiplex ligation-dependent probe amplification. J Mol Diagn ,2009,11 : 17-24.
  • 4Zhu YN, Lu SM, You JF, et al. Novel real-time PCR assay for rapid prenatal diagnosis of Down syndrome: A prospective study of 563 amniocytes. Clin Biochem, 2009, 42:6762-6765.
  • 5Cirigliano V, Voglino G, Ordonez E, et al. Rapid prenatal diagnosis of common chromosome aneuploidies by QF-PCR, results of 9 years of clinical experience. Prenat Diagn ,2009,29:40-49.
  • 6Go AT, Visser A, Betsalel OT, et al. Measurement of allelic-expression ratios in trisomy 21 placentas by quencher extension of heterozygous samples identified by partially denaturing HPLC. Clin Chem,2008,54:437-440.
  • 7Koenig M, Hoffman EP, Bertelson CJ, et al. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell, 1987, 50:509-517.
  • 8Shaw SW,Hsu JJ,Lee CN,et al.First-and secondtrimester Down syndrome screening:current strategies and clinical guidelines[J].Taiwan J Obstet Gynecol,2008,47(2):157-162.
  • 9Benn P,Wright D,Cuckle H.Practical strategies in contingent sequential screening for Down syndrome[J].Prenat Diagn,2005,25(8):645-652.
  • 10Wald N J,Watt HC,Hackshaw AK.Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters[J].N Engl J Med,1999,341(7):461-467.

共引文献70

同被引文献74

引证文献12

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部